Laboratory & hypercalcemia

Hypercalcemia Pathophysiology & Treatment

Volumn , Issue , 2009, Pages 45-61

  Cappelletti, Piero ^a   Renato, Tozzoli ^b  

^a S MARIA DEGLI ANGELI HOSPITAL   (Italy)

^b City Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882619572     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.2174/978160805107611001010045     Document Type: Chapter

References (27)

1. Toffaletti JG. Blood Gases and Electrolytes. 2nd Ed. Washington, DC: AACC Press 2009.
2. Stewart AF. Hypercalcemia associated with cancer. N Engl J Med 2005; 352: 373-379.
3. Slomp J, van der Voort PHJ, Gerritsen RT, Berk JAM, Bakker AJ. Albumin-adjusted calcium is not suitable for diagnosis of hyper- and hypocalcemia in the critically ill. Crit Care Med 2003; 31: 1389-1393.
4. Smellie WSA, Vanderpump MPJ, Fraser WD, Bowley R, Shaw N. Best practice in primary care pathology: review 11. J Clin Pathol 2008; 61: 410-8.
5. http://www.westgard.com (accessed 10.08.2009)
6. Calvi LM, Bushinsky DA. When is it appropriate to order ionized calcium? J Am Soc Nephrol 2008; 19: 1257-1260.
7. Bilezikian JP, Potts JT Jr, Fuleihan GEH, et al. Summary statement from a Workshop on asymptomatic Primary Hyperparathyroidism: a perspective for the 21st century. J Clin Endocrinol Metab 2002; 87: 5353-5361.
8. Töke J, Patócs A, Balogh K, et al. Parathyroid hormone-dependent hypercalcemia. Wien Klin Wochenschhr 2009; 121: 236-245.
9. Bilezikian JP, Khan AA, Potts JT. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J Clin Endocrinol Metab 2009; 94: 335-339.
10. Wu AHB. Tietz Clinical Guide to Laboratory Tests. 4th Ed. St. Louis: WB Saunders Company 2006.
11. Younes NA, Shafagoj Y, Khatib F, Ababneh M. Laboratory screening for hyperparathyroidism. Clin Chim Acta 2005; 353: 1-12.
12. Ricós C, Cava F, Garcia-Lario JV, et al. The reference change value: a proposal to interpret laboratory reports in serial testing based on biological variation. Scand J Clin Lab Invest 2004; 64:175-184.
13. Lumachi F, Brunello A, Roma A, Basso U. Cancer-induced hypercalcemia. Anticancer Res 2009; 29: 1551-1556.
14. National Kidney Foundation. KDOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003; 42: S1-S200.
15. Friedman PA, Goodman WG. PTH (1-84)/PTH (7-84): a balance of power. Am J Physiol Renal Physiol 2006; 290: F975-F984.
16. D'Amour P. Circulating PTH molecular forms: what we know and what we don't. Kidney Int 2006; 102 (suppl.1): S29-S33.
17. Cole DE, Webb S, Chan PC. Update on parathyroid hormone: new tests and new challenges for external quality assessment. Clin Biochem 2007; 40: 585-590.
18. Eastell R, Arnold A, Brandi ML, et al. Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab 2009; 94: 340-530.
19. Viljoen A, Singh DK, Twomey PJ, Farrington K. Analytical quality goals for parathyroid hormone based on biological variation. Clin Chem Lab Med 2008; 46: 1438-1442.
20. Joly D, Drueke TB, Alberti C, et al. Variation in serum and plasma PTH levels in second-generation assays in hemodialysis patients: a cross-sectional study. Am J Kidney Dis 2008; 51: 987-995.
21. Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R. Estimates of optimal vitamin D status. Osteoporosis Int 2005; 16: 713-716.
22. Binkley N, Kruger D, Gemar D, Drezner MK. Correlation among 25-hydroxyvitamin D assays. J Clin Endocrinol Metab 2008; 93:1804-1808.
23. Phinney KW. Development of a standard reference material for vitamin D in serum. Am J Clin Nutr 2008; 88 (suppl.): 511S-512S.
24. Bischoff-Ferrari HA. Optimal serum 25-hydroxyvitamin D levels for multiple health outcomes. Adv Exp Med Biol 2008; 624: 55-71.
25. Fritchie K, Zedek D, Grenache DG. The clinical utility of parathyroid hormone-related peptide in the assessment of hypercalcemia. Clin Chim Acta 2009; 402: 146-149.
26. Lumachi F, Ermani M, Camozzi V, Tombolan V, Luisetto G. Changes of bone formation markers osteocalcin and bone-specific alkaline phosphatase in postmenopausal women with osteoporosis. Ann N Y Acad Sci 2009; 1173: E60-E63.
27. Sokoll LJ, Wians FH Jr, Remaley AT. Rapid intraoperative immunoassay of parathyroid hormone and other hormones: a new paradigm for Point-of-Care Testing. Clin Chem 2004; 50: 1126-1135.